Exagen
(NASDAQ:XGN)
$1.58
0.18[12.86%]
At close: May 10
$1.58
0[0.00%]
After Hours: 7:50PM EDT
Q1 2024 earnings tomorrow on Mon May 13th before the market open
Conference call scheduled tomorrow at 8:30 AM Click to view the webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Exagen Stock (NASDAQ:XGN), Quotes and News Summary

Exagen Stock (NASDAQ: XGN) stock price, news, charts, stock research, profile.

Open$1.400
Close$1.570
Volume / Avg.89.034K / 32.584K
Day Range1.380 - 1.580
52 Wk Range1.300 - 3.923
Market Cap$27.423M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
62
Short Interest
0.1%
Days to Cover1

Recent News

Nike, Tencent Music Entertainment And 3 Stocks To Watch Heading Into Tuesday
With US futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Lisa Levin
Sponsored
Coya Therapeutics' Expansion Of Exclusive Worldwide Licensing Agreement With ARscience Biotherapeutics Could Have Outsized Impact On Neurodegenerative And Autoimmune Diseases Treatments
Houston, Texas-based Coya Therapeutics Inc. (NASDAQ: COYA) has just taken a giant leap in making effective proprietary treatments focused on certain neurodegenerative and autoimmune diseases available to more patients, as it announced the expansion of its exclusive worldwide rights for the development and c
FTC Solar, Exagen And 2 Other Stocks Under $3 Insiders Are Aggressively Buying
The Dow Jones closed lower by over 300 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Lisa Levin
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
XGN
NKGN

FAQ

Q

How do I buy Exagen (XGN) stock?

A

You can purchase shares of Exagen (NASDAQ: XGN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Exagen's (XGN) competitors?

A

Other companies in Exagen’s space includes: NKGen Biotech (NASDAQ:NKGN), Vincerx Pharma (NASDAQ:VINC), Serina Therapeutics (AMEX:SER), T2 Biosystems (NASDAQ:TTOO) and Evaxion Biotech (NASDAQ:EVAX).

Q

What is the target price for Exagen (XGN) stock?

A

The latest price target for Exagen (NASDAQ: XGN) was reported by Cantor Fitzgerald on Tuesday, September 26, 2023. The analyst firm set a price target for 6.00 expecting XGN to rise to within 12 months (a possible 279.75% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Exagen (XGN)?

A

The stock price for Exagen (NASDAQ: XGN) is $1.58 last updated May 10, 2024 at 7:50 PM EDT.

Q

Does Exagen (XGN) pay a dividend?

A

There are no upcoming dividends for Exagen.

Q

When is Exagen (NASDAQ:XGN) reporting earnings?

A

Exagen’s Q2 earnings are confirmed for Monday, August 5, 2024.

Q

Is Exagen (XGN) going to split?

A

There is no upcoming split for Exagen.

Q

What sector and industry does Exagen (XGN) operate in?

A

Exagen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch